Restasis

RESTASIS® is the only prescription eye drop for increasing tear production which may reduce inflammation on the eye surface in Chronic Dry Eye. Research has shown that Chronic Dry Eye (keratoconjunctivitis sicca) may be the result of a functional problem in the tear-producing glands of the eyes. This reduces tear production, resulting in an insufficient number of tears to lubricate or nourish the eye. RESTASIS® Ophthalmic Emulsion is the only prescription eye drop indicated to increase tear production which may be reduced by inflammation on the eye surface in patients with Chronic Dry Eye. Increased tear production was not seen in patients using topical steroid drops or tear duct plugs. The approved treatment is one drop in the morning and one drop at night in each eye, every day.

Unlike artificial tears, RESTASIS® Ophthalmic Emulsion helps increase your natural ability to produce tears which may be suppressed by inflammation due to Chronic Dry Eye. Chronic Dry Eye can be caused by a functional problem in the tear-producing gland of the eye. This can result in a declining quantity of tears. High risk factors for this condition include those individuals with health factors such as hormonal changes associated with aging and menopause, autoimmune diseases such as arthritis, lupus and Sjögren's syndrome. Medical conditions such as diabetes also can contribute to its onset. Indeed, many patients using RESTASIS® report a noticeable increase in tear production with continued use. Davis EyeCare can tell you whether you have Chronic Dry Eye and whether RESTASIS® should be prescribed to help increase tear production. You can help Davis EyeCare make this determination by providing a complete picture of what you’re experiencing during the eye health examination.